Hemophilia
Hemophilia is a genetic condition in which the blood-clotting process is slowed, resulting in prolonged bleeding from an injury. In severe cases, people with hemophilia spontaneously bleed when there is no obvious injury or severely bleed following a minor injury.
Quick Answer
What it is
Hemophilia is a genetic condition in which the blood-clotting process is slowed, resulting in prolonged bleeding from an injury. In severe cases, people with hemophilia spontaneously bleed when there is no obvious injury or severely bleed following a minor injury.
Key findings
- Grade A: Factor VIII Levels (Desmopressin (DDAVP))
- Grade A: von Willebrand Factor Levels (Desmopressin (DDAVP))
Safety
- In severe cases, people with hemophilia spontaneously bleed when there is no obvious injury or severely bleed following a minor injury.
ℹ️ Quick Facts
Quick Facts: Hemophilia
- Supplements Studied:1
Evidence-Based Protocol
Supplement stack ranked by research quality
Primary Stack (Tier 1)
Supports bone health; hemophilia patients at high risk for osteoporosis; deficiency common
Essential for bone health; hemophilia patients have increased osteoporosis risk
Supporting Stack (Tier 2)
May be needed if chronic blood loss leads to iron deficiency anemia; test before supplementing
Anti-inflammatory; may help with joint health; use with caution due to potential mild bleeding effect
May support joint health; hemophilic arthropathy is major complication
Supports collagen synthesis and wound healing; important for joint and tissue health
Supports red blood cell production; may be important with chronic blood loss
Supports gut health; may help with GI issues sometimes associated with hemophilia treatment
How It Works
Hemophilia is a genetic bleeding disorder caused by deficiency of clotting factors (Factor VIII in Hemophilia A, Factor IX in Hemophilia B). This results in prolonged bleeding, especially into joints (hemarthrosis) and muscles. Without treatment, repeated joint bleeds lead to hemophilic arthropathy (chronic joint damage). Modern treatment with factor replacement or newer non-factor therapies (emicizumab) has transformed outcomes.
CRITICAL: Hemophilia requires lifelong management by a specialized hemophilia treatment center. Primary treatment includes:
SUPPLEMENTS TO AVOID OR USE WITH CAUTION:
SUPPORTIVE SUPPLEMENTS:
* Vitamin D and Calcium are important because hemophilia patients have significantly higher rates of osteoporosis (up to 70% have low bone density). This is due to limited weight-bearing exercise and chronic joint disease.
* Iron may be needed if chronic bleeding causes iron deficiency. Always test before supplementing.
* Glucosamine/Chondroitin may support joint health, which is the major long-term issue in hemophilia.
* Omega-3s (moderate dose) may help with joint inflammation, but use cautiously and discuss with your hematologist.
Expected outcomes: Supplements support overall health but do not replace factor therapy or hemophilia treatment. Work closely with your hemophilia treatment center.
Detailed Outcomes
Research Citations (54)
Related Conditions
Nocturnal Enuresis
1 shared supplement · 2 outcomes
Research on nocturnal enuresis (bedwetting), primarily affecting children but also adults. Studies evaluate reduction in wet nights, sleep quality, and long-term cure rates.
Central Diabetes Insipidus
1 shared supplement · 2 outcomes
Research on central diabetes insipidus, a condition caused by deficient production of antidiuretic hormone (ADH/vasopressin) from the hypothalamus or pituitary. Studies evaluate urine output reduction, fluid balance, and quality of life.